Sfoglia per AUTORE
FERRARO E
Collezione AOU San Luigi di Orbassano

  

Items : 6

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry. in Journal of neurology / J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ferraro D; Gasperini C; Salemi G; Bergamaschi R; Lus G; Inglese M; Romano S; Bellantonio P; Di Monte E; Maniscalco GT; Conte A; Lugaresi A; Trojano M; Filippi M; Amato MP; Nica M; Ragonese P; Ruggieri S; Carotenuto A; Tortorella C; Fenu G; Onofrj M; Portaccio E; Chisari CG; Rocca MA; Ardito B; Banfi P; Nasuelli D; Paolicelli D; et alii...

Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Oct;78:104907. doi: 10.1016/j.msard.2023.104907. Epub 2023 Jul 26.
2023
AOU San Luigi di Orbassano

Petracca M; Carotenuto A; Scandurra C; Moccia M; Rosa L; Arena S; Ianniello A; Nozzolillo A; Turrini M; Streito LM; Abbadessa G; Cellerino M; Bucello S; Ferraro E; Mattioli M; Chiodi A; Inglese M; Bonavita S; Clerico M; Cordioli C; Moiola L; Patti F; Lavorgna L; Filippi M; Borriello G; D'Amico E; Pozzilli C; Brescia Morra V; Lanzillo R; et alii...

Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression. in Journal of clinical medicine / J Clin Med. 2023 Mar 13;12(6):2215. doi: 10.3390/jcm12062215.
2023
AOU San Luigi di Orbassano

Scandurra C; Rosa L; Carotenuto A; Moccia M; Arena S; Ianniello A; Nozzolillo A; Turrini M; Streito LM; Abbadessa G; Ferraro E; Mattioli M; Chiodi A; Maldonato NM; Bonavita S; Clerico M; Cordioli C; Moiola L; Patti F; Lavorgna L; Filippi M; Borriello G; D'Amico E; Pozzilli C; Brescia Morra V; Petracca M; Lanzillo R;

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano

Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC; Caleri F; Capobianco M; Capra R; Cellerino M; Centonze D; Cerqua R; Chisari CG; Clerico M; Cocco E; Cola G; Cordioli C; Curti E; d'Ambrosio A; D'Amico E; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; et alii...

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study. in Journal of neurology / J Neurol. 2021 Aug;268(8):2922-2932. doi: 10.1007/s00415-021-10455-3. Epub 2021 Feb 22.
2021
AOU San Luigi di Orbassano

Bucello S; Annovazzi P; Ragonese P; Altieri M; Barcella V; Bergamaschi R; Bianchi A; Borriello G; Buscarinu MC; Callari G; Capobianco M; Capone F; Cavalla P; Cavarretta R; Cortese A; De Luca G; Di Filippo M; Dattola V; Fantozzi R; Ferraro E; Filippi MM; Gasperini C; Grimaldi LME; Landi D; Re ML; Mallucci G; Manganotti P; Marfia GA; Mirabella M; et alii...

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study. in Journal of neurology / J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.
2018
AOU San Luigi di Orbassano

Prosperini L; Annovazzi P; Boffa L; Buscarinu MC; Gallo A; Matta M; Moiola L; Musu L; Perini P; Avolio C; Barcella V; Bianco A; Farina D; Ferraro E; Pontecorvo S; Granella F; Grimaldi LME; Laroni A; Lus G; Patti F; Pucci E; Pasca M; Sarchielli P;